Bardet-Biedl syndrome (BBS) is an inherited ciliopathy generally associated with severe obesity, but the underlying mechanism remains hypothetical and is generally proposed to be of neuroendocrine origin. In this study, we show that while the proliferating preadipocytes or mature adipocytes are nonciliated in culture, a typical primary cilium is present in differentiating preadipocytes. This transient cilium carries receptors for Wnt and Hedgehog pathways, linking this organelle to previously described regulatory pathways of adipogenesis. We also show that the BBS10 and BBS12 proteins are located within the basal body of this primary cilium and inhibition of their expression impairs ciliogenesis, activates the glycogen synthase kinase 3 pathway, and induces peroxisome proliferator-activated receptor nuclear accumulation, hence favoring adipogenesis. Moreover, adipocytes derived from BBSpatients' dermal fibroblasts in culture exhibit higher propensity for fat accumulation when compared to controls. This strongly suggests that a peripheral primary dysfunction of adipogenesis participates to the pathogenesis of obesity in BBS.
O rigins of human obesity are complex and the study of inherited obesity syndromes is of great interest in identifying specific pathways that may be also implicated in more common forms. Bardet-Biedl syndrome (BBS), an autosomal recessive disorder with extensive nonallelic heterogeneity, is mainly defined by obesity, renal dysfunction, retinal degeneration, cognitive impairment, and polydactyly (1) (2) (3) , and has been linked to a defect at the level of the primary cilium biology. The primary cilium is a microtubule-based organelle that protrudes from the surface of almost all human cells, acting as an antenna involved in extracellular signal transduction, implicating major biological pathways such as Wingless (Wnt) and Hedgehog (4, 5) . Its importance has been recently highlighted by the growing number of inherited disorders related to ciliary defects (6, 7) , illustrating the widespread tissular functions of this organelle. BBS is an emblematic ciliopathy with 12 genes identified to date (BBS1-BBS12), of which BBS1, BBS10, and BBS12 are cumulatively found mutated in more than 50% of the patients (1) . Obesity is a cardinal feature of the disease, for which the ciliary pathogenesis remains to be clarified (8) . The hypothesis of defects in the ciliated central nervous system neurons (9) that regulate fat storage has been explored and has gained recent support from studies of animal models (10) (11) (12) . Moreover, as the adipocyte has been described to be a nonciliated cell (13) and is not referenced in the list of ciliated cells (http://www.bowserlab.org/primarycilia/cilialist.html), a direct implication of this cell in the pathogenesis of BBS-associated obesity has, so far, not been investigated.
Adipocytes are derived from mesenchymal precursor cells that, when they become committed to preadipocyte lineage, can either stay dormant or undergo terminal differentiation in mature adi-pocytes in a process described as adipogenesis (14) . At this crossroad, several pathways antagonize each other: the antiadipogenic Wnt and Hh pathways are potent inhibitors of adipogenesis, whose activities need to be repressed before the cells can undergo final differentiation, whereas the peroxisome proliferator-activated receptor-␥ (PPAR␥) and CCAAT-enhancer-binding proteins (c/ EBP␣, -␤) are potent pro-adipogenic factors (15) (16) (17) . Indeed, it is now clear that PPAR␥ is the master regulator of adipogenesis because it is able to stimulate normal levels of fat cell differentiation in cells lacking C/EBP␣, whereas C/EBP␣ has no ability to induce adipogenesis in absence of PPAR␥ (18) . Wnt signaling maintains the preadipocytes in an undifferentiated state, and its inhibition is sufficient to cause spontaneous adipogenesis (19) . Hh signaling also inhibits adipocyte differentiation, but unlike Wnt total repression, Hh signaling has been described to be only reduced during adipogenic differentiation with detectable levels present in mature adipocytes (20, 21) . This down-regulation is not sufficient to trigger adipocyte differentiation, which makes Wnt signaling a more potent regulatory pathway of adipogenesis compared to Hh signaling.
Glycogen synthase kinase 3 (GSK3) is also a key regulator of adipogenesis (22) and is repressed by Wnt (19, 23) . Indeed, when the Wnt pathway is active, GSK3 is inactivated through phosphorylation and is unable to phosphorylate ␤-catenin. This leads to the nuclear translocation of ␤-catenin, which represses differentiation. In contrast, in the absence of Wnt signaling, the unphosphorylated form of GSK3 is increased, which phosphorylates ␤-catenin targeting it for proteolytic degradation (24) . This decrease in nuclear ␤-catenin is associated with the nuclear accumulation of PPAR␥. Although it is well established that Wnt and Hh pathways are playing key regulatory roles in adipogenesis, the exact cellular localization of their corresponding receptors in preadipocytes has, to our knowledge, not been determined.
We approached the pathogenesis of obesity in BBS by investigating the role of cilia-related BBS proteins in the adipocyte biology. Indeed, an up-regulation of several BBS genes during the early phase of adipogenic differentiation in culture has been recently reported (25) . In the present study we focused on 2 chaperonine-like BBS proteins that we recently identified: BBS10 (26) and BBS12 (27) . This led us to discover the transient formation of a primary cilium that carries Wnt and Hh receptors, during preadipocyte differentiation. Inhibition of BBS10 and BBS12 expression impairs this ciliogenesis and activates proadipogenic pathways implicating GSK3 and PPAR␥. Moreover, using adipocytes derived from BBS-patients' dermal fibroblasts, we were able to show increased fat accumulation in the adipocytes and higher secreted leptin levels compared to control fibroblasts.
Results
Cellular Localization of BBS10 and BBS12 Proteins. As BBS10 and BBS12 proteins have not yet been characterized, rabbit polyclonal antibodies were raised that detect in Western blots single bands of the expected size (data not shown). We used them to study the intracellular localization of the 2 endogenous proteins. The kidney tubular epithelial cells represent a well-defined and recognized model for ciliated cells (28, 29) , and moreover, kidney dysfunction is another cardinal feature in BBS patients (30, 31) . We tested the localization of BBS10 and BBS12 in human primary renal proximal tubular epithelial cells (hRPTEC). When these cells were grown to confluence, their cilium was readily immunolabeled using antiacetylated ␣-tubulin, with the basal body clearly seen at the base of the cilium (Fig. 1A ). Immunodetection of BBS10 and BBS12 proteins showed that both proteins localized to the basal body of the primary cilium. Thus, these proteins appear to share the same localization as reported for BBS6 (32) that belongs to the same vertebrate-specific family of chaperonin-like proteins (27) . This localization is thus more restricted than the localizations of the other BBS proteins belonging to the BBSome complex, which are also found in the cilium (33, 34) . In mature adipocytes derived from human white preadipocyte (HWP) [SI Text and Fig. S1 ], BBS10 and BBS12 proteins were concentrated in 2 focal points colocalizing with the ␥-tubulin-labeled centrioles, as shown in the merged pictures ( Fig. 1B) .
Ciliated Differentiating Preadipocytes. To analyze expression of BBS10 and BBS12 proteins during adipogenesis, we cultured the HWP to full confluence (D0) in preadipocyte growth medium, then switched to preadipocyte differentiation medium over 3 days, followed by a final change to adipocyte nutrition medium, leading to mature lipid accumulating adipocytes. Maximum expression levels of BBS10 and BBS12 proteins were detected in the first 2 days of adipogenic differentiation, followed by a net decrease as from day 4 to reach low basal expression levels ( Fig. 2A) . The glucose transporter4, GLUT4, was used as an adipogenic marker, expressed only in the mature adipocytes, to show that the BBS expression was progressively reduced with the proceeding of adipogenesis. This expression pattern appears thus similar to the previously described mRNA expression profile for the other BBS genes (25) . The higher expression of ciliary proteins during adipogenesis prompted us to test for the presence of a cilium at 3 different stages: subconfluent dividing preadipocyte, confluent preadipocyte corresponding to maximum expression of BBS10 and BBS12, and mature adipocyte filled with lipid droplets (Fig. 2B ). Interestingly, no cilium was detected in subconfluent preadipocytes and in mature adipocyte, but it was present in the confluent-differentiating preadipocyte. The same 3 cellular stages were examined by scanning electron microscopy, confirming the findings obtained by immunofluorescence labeling (Fig. 2C ). Transmission electron microscopy revealed the typical ultrastructural architecture of the primary cilium in the differentiating preadipocyte with the 2 centrioles, 1 at the base of cilium in the basal body ( Fig. 2D ), and the presence of lipid droplets. At higher magnification, the axoneme is seen emerging from the centriole in the basal body, which could be counted to 9 ϩ 2 doublets on a transverse section of the cilium (SI Text and Fig. S2C ).
Characterization of the Primary Cilium During Adipogenesis. BBS1, one of the 2 most frequently mutated genes in patients, codes for a subunit of the recently described BBS protein complex, the BBSome, and localizes within the primary cilium (33) . We investigated whether BBS1 and the 2 chaperonin-like proteins studied herein share this same cellular localization in the differentiating preadipocyte. We costained the differentiating adipocyte for the cilium and for BBS1, BBS10, or BBS12. BBS1 was detected all along the adipocyte cilium ( Fig. 3A ) while BBS10 and BBS12 retained their cellular localization observed in unciliated fat cell, remaining associated to the centriole in the basal body of the primary cilium ( Fig. 3 B and C) . In the renal epithelium, the primary cilium harbors receptors for pathways like Wnt and Hh (35) , whose signaling is dependent on the inherent intraflagellar transport (36) . We therefore tested if the differentiating preadipocyte primary cilium could be implicated in these pathways. We performed immunodetection of Wnt receptors using an antibody against a common epitope to the Fzzl receptors 1 to 10 ( Fig. 3D ). Specific Fzzl immunolabeling was found to localize in the cilium. In a similar way, we observed the presence on the cilium of RNAi for each gene gave similar results) ( Fig. 4 A and B) . Inhibition of BBS10 and BBS12 expression resulted in a significant reduction in the number of ciliated cells compared to control RNAi treated cells ( Fig. 4 C and D) . Because both BBS10 and BBS12 are chaperonine-like proteins and are both localized at the centriole, we wondered whether one would need the other for its centriolar localization. We performed immunofluorescence for BBS12 in BBS10-deprived cells and for BBS10 in BBS12-deprived cells ( Fig.  4 E and F) and no difference in BBS10 localization was observed after BBS12 deprivation or vice versa.
We then tested whether BBS10 and BBS12 knock down affect key regulators of adipogenesis as GSK3, ␤-catenin, and PPAR␥ based on an experimental procedure depicted in the scheme (SI Text and Fig. S3 ). Immunofluorescence detection of both the phosphorylated inactive and unphosphorylayed active forms of GSK3␤ isoform in the preadipocytes was carried out. Upon BBS10 and BBS12 inactivation, the unphosphorylated active form of GSK3 was increased compared to control transfected cells ( Fig. 5A and B for ELISA quantification). Active GSK3 represses ␤-catenin nuclear accumulation (24) . Cytoplasmic and nuclear fractions were therefore isolated from confluent preadipocytes after BBS10 and BBS12 inactivation and loaded on gel for immunodetection. Higher nuclear ␤-catenin protein content was detected in the control lane compared to the BBS10 and BBS12 knock-down lanes (Fig. 5C,  Right) . Efficient separation between the nuclear and cytoplasmic fractions was tested by Western blot using Histone H3 as a control marker (SI Text; see Fig. S1 E and F) . Indeed, histone H3 was detected only in the nuclear fraction, demonstrating good separation of the fractions. Concomitant to the reduction of nuclear ␤-catenin, inhibition of BBS10 and BBS12 expression induced a higher nuclear accumulation of PPAR␥ in differentiating preadipocytes compared to control cells (Fig. 5D ). This effect was confirmed by Western blot analysis (Fig. 5E ). The increased level of PPAR␥ is accompanied by its redistribution in the nuclei, appearing more homogenous than in cells that express normal levels of BBS10 and BBS12 proteins.
Adipocyte-Derived Fibroblasts from Patients Have a Higher Propensity
to Triglyceride Accumulation. Dermal fibroblasts from BBS10 and BBS12 patients and healthy control were cultured in fibroblast growth medium. No difference in morphology was observed between the BBS10-and BBS12-deficient cells compared to the wild-type control cells ( Fig. 6A) . At full confluence, the cells were differentiated into fat-accumulating cells as described in the SI Methods and Fig. S4 . After 14 days, the fat vacuoles were visualized in the living cells (Fig. 6B ). The intracellular triglyceride (37) levels were measured in control and BBS-deficient cells and the corresponding fluorescence levels were plotted (Fig. 6C ). Significant increase in triglyceride content was observed in the BBS patients cells compared to the control cells. Concomitant to the increased level of triglycerides present in the cells with one BBS inactivated gene, there was a significantly higher leptin level secreted in the culture medium measured by ELISA (Fig. 6D ).
Discussion
The present study demonstrates that a primary cilium is present on the confluent differentiating preadipocyte (SI Text, see Fig. S2 A  and B) . This ciliogenesis is spontaneous when full cellular confluence is reached and doesn't require serum withdrawal. In this respect, the HWP resembles the renal epithelial cells, which also exhibit spontaneous ciliogenesis. But at the difference of the renal monocilia, which is 9 ϩ 0, the primary cilium carried by the human differentiating preadipocyte has a 9 ϩ 2 (see SI Text and Fig. S2C ) structure like the nonmotile kinocilium of hair cells in the cochlea (38, 39) . Transient 9 ϩ 2 cilia may act as developmental organelles at key points of cellular differentiation in the adipocyte and the kinocilium. The reported mouse models for BBS reproduce the human overweight condition (10) . We verified that differentiating mouse preadipocytes (3T3-L1 cells) are also ciliated Fig. S2D ), indicating that this is a common feature in adipogenesis between these 2 species.
The transient ciliated status is accompanied by an increased expression of the 2 recently identified BBS genes BBS10 and BBS12, consistent with the previous findings that other BBS genes are also up-regulated during early adipogenesis (25) . The chaperonine-like BBS10 and BBS12 show centriolar/basal body localization, whereas the other BBS protein, which forms part of the BBSome, have also been detected all along the cilium as exemplified by the BBS1 detection (see Fig. 3 ). One can therefore think that BBS10 and BBS12 are required, based on their predicted function of chaperonine, in assisting the formation of ciliary components and are not directly involved in intragellar transport. Both BBS10 and BBS12 appear essential for proper ciliogenesis during adipogenesis because their absence inhibits ciliogenesis, as shown in Fig. 4 . However, they don't require each other to localize to the centrioles, as no effect was detected on their respective localization following knockdown of the other one ( Fig. 4 E and F) . Alström syndrome, another syndromic obesity condition recently classified as a ciliopathy, is caused by mutations in the ALMS1 gene coding for another ciliary protein. ALMS1 was recently shown to be regulated during adipogenesis (40) , further illustrating the prominent link between ciliary proteins and adipogenesis.
The primary cilium carries Wnt and Hh receptors, which are ancient signaling pathways and important well-recognized regulators of adipogenesis. Upon inhibition of BBS10 and BBS12 protein expression, the differentiating preadipocyte loses the cilium that carries Wnt and Hh receptors. This is likely the cause of the observed increase of the active (unphosphorylated) form of GSK3␤, associated with a decrease in the nuclear content of ␤-catenin. GSK3␤-mediated balance between ␤-catenin and PPAR␥ has been previously documented and the inactivation of ␤-catenin could favor the up-regulation of PPAR␥ (17) that we observed. Surprisingly, PPAR␥ was readily detected both by immunofluorescence and by Western blot only 24 h after adipogenic induction mediated by medium change in these human differentiating preadipocytes, which seems to be in contradiction to previous reports showing the presence of PPAR␥ only 48 h after induction of adipogenesis (15, 41, 42) . The expression of PPAR␥ has been extensively studied in murine models, especially the 3T3-L1 preadipocytes, which require mitotic clonal expansion before they can start expressing the genes producing the adipocyte phenotype including PPAR␥ (43) . A major difference exists between the widely studied 3T3-L1 preadipocyte model and the primary human preadipocyte used in the present study, as human preadipocytes can proceed through terminal differentiation without postconfluence mitosis (44) , which may account for the earlier expression of PPAR␥ after adipogenic induction. To ascertain the proadipogenic effect of BBS10 and BBS12 deprivation, we knocked down BBS10 and BBS12 in conf luent preadipocytes and kept culturing them in the preadipocyte growth medium, a specially formulated medium to prevent adipogenesis, for 48 h before analyzing PPAR␥ expression (see SI Text and Fig. S2F ). PPAR␥ was readily detected in the extract from the BBS10and BBS12-deprived preadipocytes and remained almost undetectable in the control lysate. This proves that the absence of the cilium following BBS10 or BBS12 inactivation is sufficient to induce adipogenesis, probably by disrupting Wnt signaling, which could not be detected after the BBS knock down (data not shown). The lipid-derived fluorescence was measured at 572 nm for each condition (CONT for the wild-type healthy fibroblasts, BBS10-, and BBS12-mutated fibroblasts) and was expressed as total measured fluorescence per cell. (n ϭ 3) (control compared to BBS10: P ϭ 0.001 and control compared to BBS12: P Ͻ 0.001). (D) Secreted leptin was measured in the culture medium by ELISA and was expressed as the total absorbance at 450 nm per cell. In parallel with the increased intracellular triglyceride content, higher quantities of leptin was detected in the medium from the BBS mutated cells compared to the healthy control (n ϭ 3) (control compared to BBS10: P ϭ 0.05 and control compared to BBS12: P ϭ 0.03).
Although stable gene knockdowns are useful, human fibroblasts from patients with characterized mutations often represent an invaluable tool to investigate the related diseases. Here, we were able to culture and reprogram dermal fibroblasts from two BBS patients to lipid-accumulating cells expressing PPAR␥ and GLUT4 (see SI Text, Methods, and Fig. S4 ). Interestingly, during the culture of these cells, no difference was observed in cell growth or in structural cellular aspects (data not shown), although it has been described that BBS6, the other chaperonine-like protein of the BBS family, blocked cytokinesis yielding abnormal polynucleated cells (32) . BBS6 protein may therefore possess a specific role in cell division, which both BBS10 and BBS12 don't share. Based on the effect observed on PPAR␥ expression after specific BBS knockdown in the differentiating preadipocytes, intracellular triglyceride content and secreted leptin levels were measured, and significant increase in intracellular triglyceride contents was observed in the BBS mutated cells compared to the control cells (see Fig. 6 B-D) . It is well recognized that leptin secretion is directly correlated to adiposity. An increase in leptin secretion was measured in the culture medium from the BBS mutated cells compared to the control cells, reproducing the human-observed phenotype of highcirculating leptin concentrations.
The pathophysiological pathways leading to obesity in the BBS patients have been suggested to be related to central nervous system control of body weight. BBS proteins are required for proper ciliary localization in neurons of the Mchr1 receptor, involved in regulation of feeding behavior (12) . Hypothalamic ciliated neurons may be involved in the leptin resistance recently described in BBS patients and obese BBS knockout mouse models (10, 45) . BBS gene inactivation in these neurons has been shown to reduce Pomc expression, a gene activated by leptin via Stat3 (10) . Nonetheless, this reduction cannot solely explain the extreme increase in body weight because the mice with specific inactivation of Stat3 and subsequent decreased Pomc expression exhibit a mild increase in total body weight and only a 2-fold increase in fat pad mass (46) . The results presented in this article point out that the BBSassociated obesity may have a dual origin: the suggested central nervous system origin (10, 11) combined with a peripheral origin by increased adipogenesis via inhibition of Wnt signaling.
Lipodystrophy syndromes are to date the only syndromes related to primary abnormalities in adipogenesis. Obesity related to impaired adipogenesis has, so far, not been reported, and it is believed that body mass increase is not directly related to the adipocyte differentiation. Very recently however, Cao et al. (47) presented evidence for a lipid-mediated endocrine network where the adipose tissue itself uses lipokines to communicate with other organs and regulate systemic metabolic homeostasis. We therefore suggest that adipogenesis itself may participate to the pathogenesis of obesity. This hypothesis warrants further investigations in vivo. To address this question and to dissect the associated molecular parameters, conditional knockout mice will be used to target specific BBS inactivation in the adipose tissue, which will allow us to understand the role of enhanced adipogenesis in the BBS-induced obesity.
Materials and Methods
For details, please see SI Methods.
